Logo image of JCTC

JEWETT-CAMERON TRADING LTD (JCTC) Stock Fundamental Analysis

NASDAQ:JCTC - Nasdaq - CA47733C2076 - Common Stock - Currency: USD

3.78  -0.04 (-0.92%)

Fundamental Rating

3

Overall JCTC gets a fundamental rating of 3 out of 10. We evaluated JCTC against 41 industry peers in the Building Products industry. No worries on liquidiy or solvency for JCTC as it has an excellent financial health rating, but there are worries on the profitability. JCTC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year JCTC has reported negative net income.
JCTC had a negative operating cash flow in the past year.
Of the past 5 years JCTC 4 years were profitable.
In multiple years JCTC reported negative operating cash flow during the last 5 years.
JCTC Yearly Net Income VS EBIT VS OCF VS FCFJCTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

JCTC has a worse Return On Assets (-4.59%) than 80.49% of its industry peers.
JCTC has a worse Return On Equity (-5.35%) than 78.05% of its industry peers.
Industry RankSector Rank
ROA -4.59%
ROE -5.35%
ROIC N/A
ROA(3y)1.97%
ROA(5y)5.94%
ROE(3y)2.55%
ROE(5y)7.42%
ROIC(3y)N/A
ROIC(5y)N/A
JCTC Yearly ROA, ROE, ROICJCTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

JCTC's Profit Margin has declined in the last couple of years.
JCTC's Gross Margin of 17.65% is on the low side compared to the rest of the industry. JCTC is outperformed by 85.37% of its industry peers.
JCTC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for JCTC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-36.57%
PM growth 5Y-19.82%
GM growth 3Y-8.51%
GM growth 5Y-2.97%
JCTC Yearly Profit, Operating, Gross MarginsJCTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

9

2. Health

2.1 Basic Checks

JCTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JCTC remains at a similar level compared to 1 year ago.
JCTC has less shares outstanding than it did 5 years ago.
JCTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JCTC Yearly Shares OutstandingJCTC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
JCTC Yearly Total Debt VS Total AssetsJCTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 5.46 indicates that JCTC is not in any danger for bankruptcy at the moment.
JCTC has a better Altman-Z score (5.46) than 70.73% of its industry peers.
There is no outstanding debt for JCTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.46
ROIC/WACCN/A
WACC10.01%
JCTC Yearly LT Debt VS Equity VS FCFJCTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

JCTC has a Current Ratio of 5.84. This indicates that JCTC is financially healthy and has no problem in meeting its short term obligations.
JCTC has a Current ratio of 5.84. This is amongst the best in the industry. JCTC outperforms 92.68% of its industry peers.
JCTC has a Quick Ratio of 2.07. This indicates that JCTC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.07, JCTC belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.84
Quick Ratio 2.07
JCTC Yearly Current Assets VS Current LiabilitesJCTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for JCTC have decreased strongly by -171.27% in the last year.
JCTC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.25% yearly.
Looking at the last year, JCTC shows a decrease in Revenue. The Revenue has decreased by -8.09% in the last year.
Measured over the past years, JCTC shows a small growth in Revenue. The Revenue has been growing by 0.74% on average per year.
EPS 1Y (TTM)-171.27%
EPS 3Y-40.74%
EPS 5Y-16.25%
EPS Q2Q%-6.67%
Revenue 1Y (TTM)-8.09%
Revenue growth 3Y-6.4%
Revenue growth 5Y0.74%
Sales Q2Q%10.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JCTC Yearly Revenue VS EstimatesJCTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JCTC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JCTC Price Earnings VS Forward Price EarningsJCTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JCTC Per share dataJCTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JCTC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JEWETT-CAMERON TRADING LTD

NASDAQ:JCTC (6/18/2025, 8:00:02 PM)

3.78

-0.04 (-0.92%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)07-14 2025-07-14
Inst Owners17.31%
Inst Owner ChangeN/A
Ins Owners1.24%
Ins Owner Change-5.94%
Market Cap13.31M
AnalystsN/A
Price TargetN/A
Short Float %0.99%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS13.48
BVpS6.73
TBVpS6.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.59%
ROE -5.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.65%
FCFM N/A
ROA(3y)1.97%
ROA(5y)5.94%
ROE(3y)2.55%
ROE(5y)7.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-36.57%
PM growth 5Y-19.82%
GM growth 3Y-8.51%
GM growth 5Y-2.97%
F-Score2
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.84
Quick Ratio 2.07
Altman-Z 5.46
F-Score2
WACC10.01%
ROIC/WACCN/A
Cap/Depr(3y)160.02%
Cap/Depr(5y)233.59%
Cap/Sales(3y)0.88%
Cap/Sales(5y)1.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-171.27%
EPS 3Y-40.74%
EPS 5Y-16.25%
EPS Q2Q%-6.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.09%
Revenue growth 3Y-6.4%
Revenue growth 5Y0.74%
Sales Q2Q%10.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1504.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-289.47%
FCF growth 3YN/A
FCF growth 5Y-1.18%
OCF growth 1Y-153.67%
OCF growth 3YN/A
OCF growth 5Y-0.91%